Whitebox Advisors’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.23M Hold
305,000
0.04% 165
2025
Q4
$3.2M Hold
305,000
0.05% 160
2025
Q3
$3.16M Hold
305,000
0.05% 155
2025
Q2
$3.13M Hold
305,000
0.07% 153
2025
Q1
$3.07M Buy
+305,000
New +$3.06M 0.08% 141

Other funds holding TDAC

Whitebox Advisors's TDAC Position: Q1 2026 in Review

Whitebox Advisors held its Translational Development Acquisition Corp (TDAC) position steady in Q1 2026 at 305,000 shares worth $3.23M. The position accounts for 0.04% of the portfolio, ranked #165.

Whitebox Advisors first reported a position in TDAC in Q1 2025 and has held it in 5 quarters since. 48 funds tracked by Wall St. Rank hold TDAC as of Q1 2026.

  • Whitebox Advisors held 305,000 shares of Translational Development Acquisition Corp worth $3.23M as of Q1 2026.
  • Whitebox Advisors left its Translational Development Acquisition Corp share count unchanged in Q1 2026.
  • Translational Development Acquisition Corp made up 0.04% of Whitebox Advisors's portfolio in Q1 2026, its #165 holding.
  • Whitebox Advisors first reported a position in Translational Development Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
  • 48 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q1 2026.

Based on Whitebox Advisors's 13F filing for Q1 2026, filed 15 May 2026.